76 results
Page 2 of 4
8-K
EX-1.1
yy9eo4xgdzjyj0ua
30 Mar 22
Soleno Therapeutics Announces Pricing of Approximately $15 Million Underwritten Public Offering
5:24pm
424B5
mqo79hj6ukn
30 Mar 22
Prospectus supplement for primary offering
5:21pm
424B5
je1oulu3ollj9xa
28 Mar 22
Prospectus supplement for primary offering
4:53pm
8-K
EX-1.1
u46hn6nzich g64pzs
16 Jul 21
Entry into a Material Definitive Agreement
4:14pm
CORRESP
p3qgdo
5 Feb 21
Correspondence with SEC
12:00am
8-K
h9n9w3h1
13 Nov 20
Termination of a Material Definitive Agreement
4:02pm
8-K
EX-10.1
k2vu39
2 Oct 20
Departure of Directors or Certain Officers
4:49pm
S-8
EX-4.2
5ee68ewxuu0stub
26 Jun 20
Registration of securities for employees
5:01pm
8-K
EX-1.1
x62a6uaxnx2xpkg xv
26 Jun 20
Soleno Therapeutics Announces Pricing of $50 Million Public Offering of Common Stock
4:31pm
424B5
x4tei0 4o1b2xkkisevw
25 Jun 20
Prospectus supplement for primary offering
4:01pm
424B5
e3yry5v91
23 Jun 20
Prospectus supplement for primary offering
4:06pm
8-K
EX-1.1
kbtee
25 Oct 19
Soleno Therapeutics Announces Pricing of $13.4 Million Public Offering of Common Stock
4:03pm
CORRESP
kakagb jzxs98d9j
22 Jul 19
Correspondence with SEC
12:00am